These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6266964)

  • 1. Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients.
    Arsenakis M; May JT
    Infect Immun; 1981 Jul; 33(1):22-8. PubMed ID: 6266964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ELISA technique to detect IgG antibody to the early herpes simplex virus type 2 (HSV-2) antigen AG-4 in HSV-2 patients.
    Evans L; Arsenakis M; Sheppard M; May JT
    J Virol Methods; 1983 May; 6(5):245-54. PubMed ID: 6308025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.
    Sherlock CH; Ashley RL; Shurtleff ML; Mack KD; Corey L
    J Clin Microbiol; 1986 Dec; 24(6):1093-7. PubMed ID: 3023439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to the herpes simplex virus type 2 AG-4 antigen in guinea pigs with genital herpes infections.
    Maragos C; Miller A; May JT
    Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():89-95. PubMed ID: 3008691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of herpes simplex virus type 2 infections in herpes-like genital lesions by a simple complement-fixation test.
    Arsenakis M; May JT
    Br J Vener Dis; 1982 Feb; 58(1):48-51. PubMed ID: 6275941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.
    Skinner GR; Hartley CH; Whitney JE
    Arch Virol; 1976; 50(4):323-33. PubMed ID: 179502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of the major herpes simplex virus type 1 (HSV-1)-specific glycoprotein by hydroxylapatite chromatography and its use in enzyme-linked immunosorbent assay for titration of human HSV-1-specific antibodies.
    Vestergaard BF; Grauballe PC
    J Clin Microbiol; 1979 Dec; 10(6):772-7. PubMed ID: 230199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the HSV-2 early AG-4 antigen.
    Evans LA; Sheppard M; May JT
    Arch Virol; 1985; 85(1-2):13-23. PubMed ID: 2990385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual serologic response to two patients to an early antigen of herpes simplex virus type 2.
    Arsenakis M; May JT
    Sex Transm Dis; 1982; 9(3):143-5. PubMed ID: 6293106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
    Schmidt NJ; Gallo D
    J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
    Källander CF; Torfason EG; Olding-Stenkvist E; Sundqvist VA; Diderholm H; Gronowitz JS
    J Med Virol; 1989 May; 28(1):30-7. PubMed ID: 2542443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complement.
    Cromeans TL; Shore SL
    Infect Immun; 1981 Mar; 31(3):1054-61. PubMed ID: 6262246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
    Aurelian L; Smith MF; Cornish DJ
    J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of type 2 herpes simplex virus complement-fixing antigen.
    Palmer EL; Martin ML; Warfield DT
    Appl Microbiol; 1971 Nov; 22(5):925-7. PubMed ID: 4332046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.
    Schmidt NJ; Dennis J; Lennette EH
    Infect Immun; 1977 Mar; 15(3):850-4. PubMed ID: 192677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.
    Subramanian T; Rawls WE
    J Clin Microbiol; 1977 Jun; 5(6):551-8. PubMed ID: 195975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative complement fixation and serum neutralization antibody titers to herpes simplex virus type 1 and Herpesvirus simiae in Macaca mulatta and humans.
    Gary GW; Palmer EL
    J Clin Microbiol; 1977 Apr; 5(4):465-70. PubMed ID: 192762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
    Christenson B; Espmark A
    Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.